COB20_WEREWOLF_FASTSEAL_Beauty_Wand_Tip_25202-Hero1.png

Precision powered performance in total joint hemostasis

The FASTSEAL 6.0 Wand is a next-generation bipolar sealer (BPS) engineered to achieve effective hemostasis while addressing key limitations of monopolar electrocautery.1-4 Using our leading WEREWOLF+ System technology, the proprietary wand is designed to offer a slim and maneuverable profile to support surgeon control in demanding procedures.

Aim for a new era of performance and value

With one controller unit usable across multiple surgical disciplines and indications, the FASTSEAL Wand adds to a broader range of applications designed to help streamline operating room equipment needs.



Medical education

Disclaimers

*Emissions included toluene, benzene and acrylonitrile; as demonstrated ex vivo at maximum settings, n=6 devices.

**Compared to monopolar electrocautery, demonstrated in total knee arthroplasty. n=123. Acute blood loss - p=0.001; Total blood loss - p=0.04. Lower blood transfusion rate – p=0.04.

***Shorter procedure time demonstrated in infected revision total knee arthroplasty; p=0.044, n=80.

****As demonstrated in vivo at maximum setting in a beef heart soft tissue model. Single device tested 30 times.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

Citations
  1. Marulanda GA, et al. Expert Rev Med Devices. 2008;5(2):125-131.
  2. Derman PB, et al. Am J Orthop (Belle Mead NJ). 2013;42(9):407-411.
  3. Smith+Nephew 2021. Internal Report. 110180-02 Rev A.
  4. Epstein NJ. Poster presented at: Orthopaedic Research Society (ORS) Annual Meeting; February 7–11, 2025; Phoenix, AZ
  5. Smith+Nephew 2021. Internal Report. 110154-01 Rev
  6. Smith+Nephew 2021. Internal Report. 110127-01 Rev A.
  7. Smith+Nephew 2021. Internal Report. EO.SPM.PCS.037.001.v1.
  8. Smith+Nephew 2021. Internal Report. 21-0006A-01 Rev A.
  9. Smith+Nephew 2021. Internal Engineering protocol. 21-0006A Rev A.
  10. Smith+Nephew 2021. Internal Report. 21-0005-01 Rev A. 

Title

Text